In China, A Province's Drastic Price Cut Model Is Being Modified To Fit A Nationwide System: A Look At The Anhui Model
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Since China's healthcare reforms started in 2009, the central government has been encouraging local government to pilot different tender models for essential drugs to reduce public medical expenses. Anhui Province's tender system became a successful example by reducing essential drug prices an average 40-50% last year, and now the central government is implementing a single supplier procurement system, the so-called Anhui model, nationwide
You may also be interested in...
New Growth Models In China: McKinsey-PharmAsia Summit Report Preview
With increased pricing pressure on branded generics, MNCs in China need to fundamentally redesign their business models with stronger market-access capabilities and to shift resources away from brands under acute pressure to support those with bigger future potential, according to a survey conducted by McKinsey & Company.
New Growth Models In China: McKinsey-PharmAsia Summit Report Preview
With increased pricing pressure on branded generics, MNCs in China need to fundamentally redesign their business models with stronger market-access capabilities and to shift resources away from brands under acute pressure to support those with bigger future potential, according to a survey conducted by McKinsey & Company.
Will A Powerful New Ministry Lead To A Favorable Regulatory Environment In China?
With its organizational structure in place and a roadmap of responsibilities published, China’s now powerful National Health and Family Planning Commission could bring about a new age of regulatory efficiency.